Selenium

Most people who start supplementing selenium feel nothing at all, and that is exactly what the pharmacology would predict. Selenium works at the enzymatic level, optimizing antioxidant defenses and thyroid hormone conversion in ways that do not produce any immediate subjective sensation. If your selenium status was already adequate from diet, supplementation is biochemically redundant and you should not expect to notice a difference.

The exception is people who were genuinely deficient. Those with subclinical selenium insufficiency, particularly common in regions with selenium-poor soils, sometimes report a gradual improvement in energy levels, mood stability, and mental clarity over several weeks. This is likely mediated through restored deiodinase activity normalizing T4-to-T3 conversion, effectively correcting a subtle thyroid bottleneck that was dragging down metabolism and cognition. People with Hashimoto's thyroiditis seem to notice the most, with some reporting that selenium was the missing piece alongside their thyroid medication. Community discussions consistently emphasize the same theme: if it works for you, the effect is real but quiet, a slow lift rather than anything you would call noticeable on a given day.

Selenium is a trace element uniquely incorporated into proteins as selenocysteine — the 21st amino acid — through a specialized UGA stop codon readthrough mechanism using the SECIS element in mRNA. The human selenoproteome comprises 25 selenoproteins with critical physiological roles.

Glutathione peroxidases (GPx1-4): Reduce hydrogen peroxide and organic hydroperoxides to water and alcohols, protecting cellular membranes from oxidative damage. GPx4 is particularly critical for neuronal survival and for suppressing ferroptosis (an iron-dependent, regulated cell death pathway implicated in neurodegeneration).

Thioredoxin reductases (TrxR1-3): Maintain the thioredoxin redox system, which regulates numerous redox-sensitive signaling proteins, DNA synthesis (ribonucleotide reductase), antioxidant defense (reducing oxidized glutathione peroxidase and vitamin C), and NFkappaB signaling.

Iodothyronine deiodinases (DIO1, DIO2, DIO3): Regulate tissue concentrations of thyroid hormones by converting T4 (thyroxine) to the active T3 (triiodothyronine) form (DIO1, DIO2) or inactivating thyroid hormones (DIO3). Selenium deficiency impairs T4 → T3 conversion, causing functional hypothyroidism even when iodine and TSH are normal.

Selenoprotein P (SELENOP): The principal selenium transport protein, synthesized in the liver and released to deliver selenium to tissues. Brain selenium is maintained preferentially even during systemic deficiency, with SELENOP and its receptor ApoER2 (the same LDL-receptor family member involved in Alzheimer's pathology) mediating brain selenium uptake.

Selenoprotein M and W: Found in abundance in brain tissue; roles in calcium regulation and neuroprotection.

The mood effects of selenium supplementation likely arise from: restoration of thyroid function (selenium-dependent T3 production), maintenance of brain redox balance, and potentially direct effects on monoamine oxidase and catecholamine metabolism (selenium-dependent thioredoxin reductase regulates MAO activity).

Selenium was discovered in 1817 by Swedish chemists Jöns Jacob Berzelius and Johan Gottlieb Gahn, who identified it as a contaminant in sulfuric acid from a Swedish copper refinery. Berzelius named it after Selene, the Greek goddess of the Moon, as selenium's properties resembled the related element tellurium (named after Terra, Earth).

For the first century after discovery, selenium was regarded as primarily toxic — selenium poisoning in livestock ("alkali disease" in the American Great Plains) was a major agricultural problem in the early 20th century, where animals grazing on selenium-accumulating plants in high-selenium soil areas became sick and died. This established selenium as a known toxin before its essential function was discovered.

The nutritional essentiality of selenium was established in 1957 by Klaus Schwarz and Calvin Foltz, who showed that selenium prevented liver necrosis in vitamin E-deficient rats — a critical finding that reframed selenium from pure toxin to essential trace element. The selenium-containing enzyme glutathione peroxidase was characterized in 1973 by J.T. Rotruck and colleagues, providing the first molecular understanding of selenium's essential role.

Keshan disease — a cardiomyopathy endemic to selenium-deficient regions of China — became the clearest human example of selenium deficiency disease in the 1970s–1980s. The Chinese government's response, including sodium selenite supplementation programs, dramatically reduced Keshan disease incidence and firmly established selenium's essentiality in human nutrition.

The identification of selenocysteine as the 21st amino acid (the only other amino acid besides the standard 20 to have its own codon mechanism) in 1986–1989 was a landmark in molecular biology, revealing the unique genetic encoding of selenium's incorporation into proteins. Ongoing research continues to characterize the selenoproteome and its roles in aging, neurodegeneration, immune function, and cancer.